Could be short covering - could be insiders friends that know going into earnings as grey mentions below - long shot being acquired at $12-$14 nobody know but FEELS GREAT! Close to breaking past 9.61 or so high of many years!
Hey Quant, I am with you --- I am excited about the long term prospects for this solid cash-flow biotech. I also kind of backed into this one a couple of years ago. Took a chance on the management and it seems that they are 'for real' unlike so many in the industry.
If anyone knows of another small, cash-flow biotech then I am all ears!
Grey - Bought in about 7 - 8 years ago so its been a GRIND - played the patent win angle and they prevailed but no action and at the mercy of fda - THEY ALSO GOT FORTUNATE AND BACKED INTO BIOPROCESSING - so we are all fortunate. Prospects moving forward look very strong and secure. As always good luck to all - cannot imagine being short.